The FINANCIAL — Nestlé on April 24 inaugurated two new factories in the China Medical City in Taizhou.
The factories will meet the needs of consumers for Foods for Special Medical Purposes (FSMP) and skin care products, according to Nestlé.
The CHF 150 million investment for the new factories of Nestlé Health Science and Nestlé Skin Health adds to Nestlé’s existing production set up and underscores the company’s confidence in the future prospects of the Chinese market.
The two state-of-the-art factories utilize best-in-class technologies to ensure the highest levels of quality assurance and manufacturing efficiency. They will also contribute to the development of the local economy.
Magdi Batato, Executive Vice President, Head of Operations for Nestlé S.A: “Nestlé is fully committed to continue to invest to support sustainable growth in China. By bringing the manufacturing capabilities of Nestlé Health Science and Nestlé Skin Health to China, we are in a stronger position to enhance Nestlé’s product offering and meet consumer expectations.”
Nestlé has identified consumer healthcare as an addition growth platform, complementary to its core food and beverage business. The new investment underscores Nestlé’s purpose to enhance quality of life and contribute to healthier future.
Discussion about this post